Page last updated: 2024-08-23

simvastatin and Shock

simvastatin has been researched along with Shock in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Capuano, A; Cuzzocrea, S; Di Palma, D; Donniacuo, M; Esposito, E; Mazzon, E; Paterniti, I; Rinaldi, B; Rossi, F; Sodano, L	1

Other Studies

1 other study(ies) available for simvastatin and Shock

Article	Year
PPARα mediates the anti-inflammatory effect of simvastatin in an experimental model of zymosan-induced multiple organ failure. British journal of pharmacology, 2011, Volume: 163, Issue:3 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Dose-Response Relationship, Drug; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Interleukin-1beta; Intestinal Mucosa; Intestines; Kidney; Liver; Lung; Mice; Mice, Knockout; Multiple Organ Failure; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; PPAR alpha; Shock; Simvastatin; Tumor Necrosis Factor-alpha; Up-Regulation; Zymosan	2011

Article

Year

PPARα mediates the anti-inflammatory effect of simvastatin in an experimental model of zymosan-induced multiple organ failure.

British journal of pharmacology, 2011, Volume: 163, Issue:3

Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Dose-Response Relationship, Drug; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Interleukin-1beta; Intestinal Mucosa; Intestines; Kidney; Liver; Lung; Mice; Mice, Knockout; Multiple Organ Failure; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; PPAR alpha; Shock; Simvastatin; Tumor Necrosis Factor-alpha; Up-Regulation; Zymosan

2011